Impaired intestinal iron absorption in Crohn's disease correlates with disease activity and markers of inflammation

Inflammatory Bowel Diseases

Volumn 12, Issue 12, 2006, Pages 1101-1106

  Semrin, Gaith ^a,d   Fishman, Douglas S ^a   Bousvaros, Athos ^a   Zholudev, Anna ^a   Saunders, Andrew C ^b   Correia, Catherine E ^b,f   Nemeth, Elizabeta ^e   Grand, Richard J ^a,c,g   Weinstein, David A ^b,f  

^a Center for Inflammatory Bowel Disease   (United States)

^b General Clinical Research Center and Infectious Disease Unit   (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

^d CHILDREN S MEDICAL CENTER   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^g HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Hepcidin; Inflammatory bowel disease; Interleukin 6; Pediatric

Indexed keywords

BIOCHEMICAL MARKER; C REACTIVE PROTEIN; CYTOKINE; FERROUS SULFATE; HEMOGLOBIN; HEPCIDIN; INTERLEUKIN 6; IRON;

ADOLESCENT; ADULT; ANEMIA; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CORRELATION COEFFICIENT; CROHN DISEASE; DIET SUPPLEMENTATION; DISEASE ACTIVITY; DRUG BLOOD LEVEL; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; INFLAMMATION; INTESTINE ABSORPTION; IRON ABSORPTION; IRON BLOOD LEVEL; MALE; PEDIATRICS; PRIORITY JOURNAL; SCHOOL CHILD; URINALYSIS;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; CHILD; CROHN DISEASE; CYTOKINES; DEMOGRAPHY; FEMALE; HUMANS; INFLAMMATION; INTESTINAL ABSORPTION; IRON; MALABSORPTION SYNDROMES; MALE;

EID: 33751579324     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1097/01.mib.0000235097.86360.04     Document Type: Article

References (35)

1. Thayu M LM, Baldassano RN, Mamula P. Prevalence of anemia in incident pediatric Crohn disease. J Pediatr Gasteroenterol Nutr. 2005;41:547. (Abstract).
2. Burbige EJ, Huang SH, Bayless TM. Clinical manifestations of Crohn's disease in children and adolescents. Pediatrics. 1975;55:866-871.
3. Wilson A, Reyes E, Ofman J. Prevalence and outcomes of anemia in inflammatory bowel disease: a systematic review of the literature. Am J Med. 2004;116(suppl 1):44-49.
4. Han OW, Weaver V. Hepcidin down-regulates iron transport across the human intestinal cells. Presented at FASEB Meeting, San Francisco, CA April 2, 2006. FASEB J 120: Progr Abstr # 112.1. Available at: http://www.eb2006-online.com/ pdfs/008702.PDF?PHPSESSID=f07543fef8761587d860af5e0239a3bf.
5. Nemeth E, Rivera S, Gabayan V, et al. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin 10.1172/JCI200420945. J Clin Invest. 2004;113:1271-1276.
6. Knutson MD, Oukka M, Koss LM, et al. Iron release from macrophages after erythrophagocytosis is up-regulated by ferroportin 1 overexpression and down-regulated by hepcidin 10.1073/pnas.0409409102. Proc Natl Acad Sci USA 2005;102:1324-1328.
7. Fleming RE, Sly WS. Hepcidin: a putative iron-regulatory hormone relevant to hereditary hemochromatosis and the anemia of chronic disease. Proc Natl Acad Sci USA 2001;98:8160-8162.
8. Park CH, Valore EV, Waring AJ, et al. Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem. 2001;276:7806-7810.
9. Rivera S, Nemeth E, Gabayan V, et al. Synthetic hepcidin causes rapid dose-dependent hypoferremia and is concentrated in ferroportin-containing organs. Blood. 2005;106:2196-2199.
10. Nicolas G, Bennoun M, Porteu A, et al. Severe iron deficiency anemia in transgenic mice expressing liver hepcidin. Proc Natl Acad Sci USA 2002;99:4596-4601.
11. Nicolas G, Bennoun M, Devaux I, et al. Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice. Proc Natl Acad Sci USA 2001;98:8780-8785.
12. Weinstein DA, Roy CN, Fleming MD, et al. Inappropriate expression of hepcidin is associated with iron refractory anemia: implications for the anemia of chronic disease. Blood. 2002;100:3776-3781.
13. Voulgari PV, Kolios G, Papadopoulos GK, et al. Role of cytokines in the pathogenesis of anemia of chronic disease in rheumatoid arthritis. Clin Immunol. 1999;92:153-160.
14. Bross DA, Leichtner AM, Zurakowski D, et al. Elevation of serum interleukin-6 but not serum-soluble interleukin-2 receptor in children with Crohn's disease. J Pediatr Gastroenterol Nutr. 1996;23:164-171.
15. Gross V, Andus T, Caesar I, et al. Evidence for continuous stimulation of interleukin-6 production in Crohn's disease. Gastroenterology. 1992;102:514-519.
16. Hyams J, Fitzgerald J, Treem W, et al. Relationship of functional and antigenic interleukin 6 to disease activity in inflammatory bowel disease. Gastroenterology. 1993;104:1285-1292.
17. Gross SJ, Stuart MJ, Swender PT, et al. Malabsorption of iron in children with iron deficiency. J Pediatr. 1976;88:795-799.
18. Jensen NM, Brandsborg M, Boesen AM, et al. Low-dose oral iron absorption test in anaemic patients with and without iron deficiency determined by bone marrow iron content. Eur J Haematol. 1999;63:103-111.
19. Gasche C, Scholmerich J, Brynskov J, et al. A simple classification of Crohn's disease: report of the working party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm Bowel Dis. 2000;6:8-15.
20. Hyams JS, Ferry GD, Mandel FS, et al. Development and validation of a pediatric Crohn's disease activity index. J Pediatr Gastroenterol Nutr. 1991;12:439-447.
21. Nemeth E, Valore EV, Territo M, et al. Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood. 2003;101:2461-2463.
22. Moore CV, Doan CA, Arrowsmith WR. Studies in iron transportation and metabolism, II: the mechanism of iron transportation: its significance in iron utilization in anemic states of varied etiology. J Clin Invest. 1937;16:627-648.
23. Fleming RE, Bacon BR. Orchestration of iron homeostasis. N Engl J Med. 2005;352:1741-1744.
24. Gunshin H, Mackenzie B, Berger UV, et al. Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature. 1997;388:482-488.
25. Gunshin H, Allerson CR, Polycarpou-Schwarz M, et al. Iron-dependent regulation of the divalent metal ion transporter. FEBS Lett. 2001;509:309-316.
26. McKie AT, Marciani P, Rolfs A, et al. A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation. Mol Cell. 2000;5:299-309.
27. Donovan A, Brownlie A, Zhou Y, et al. Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter. Nature. 2000;403:776-781.
28. Knutson MD, Vafa MR, Haile DJ, et al. Iron loading and erythrophagocytosis increase ferroportin 1 (FPN1) expression in J774 macrophages. Blood. 2003;102:4191-4197.
29. Nemeth E, Tuttle MS, Powelson J, et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science. 2004;306:2090-2093.
30. Krause A, Neitz S, Magert HJ, et al. LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity. FEBS Lett. 2000;480:147-150.
31. Nicolas G, Chauvet C, Viatte L, et al. The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. J Clin Invest. 2002;110:1037-1044.
32. Weinstein DA, Roy CN, Fleming MD, et al. Inappropriate expression of hepcidin is associated with iron refractory anemia: implications for the anemia of chronic disease. Blood. 2002;100:3776-3781.
33. Huang FW, Pinkus JL, Pinkus GS, et al. A mouse model of juvenile hemochromatosis. J Clin Invest. 2005;115:2187-2191.
34. Yeh KY, Yeh M, Glass J. Hepcidin regulation of ferroportin 1 expression in the liver and intestine of the rat. Am J Physiol Gastrointest Liver Physiol. 2004;286 G385-G394.
35. Lanzkowsky P, Karayalcin G, Betkerur U, et al. Unreliability of the oral iron absorption test. J Pediatr. 1977;90(3):494-496.